$HCWB

$1.10 -$0.07 (5.98%) Close

$HCWB Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$HCWB Management Team

Mr. Lee Flowers

Senior Vice President - Business Development

Age 79

Compensation -

Sex Male

Mr. Scott Garrett

Independent Chairman of the Board

Age 75

Compensation $70.57K USD

Sex Male

Dr. Hing Wong

Chief Executive Officer

Founder

Director

Age 71

Compensation $368.2K USD

Sex Male

Ms. Rebecca Byam

Chief Financial Officer

Age 69

Compensation $154.2K USD

Sex Female

Dr. Peter Rhode

Chief Scientific Officer

Vice President - Clinical Operations

Age 67

Compensation $261.7K USD

Sex Male

Name / Title	Age	Compensation	Sex
Mr. Lee Flowers Senior Vice President - Business Development	79	-	Male
Mr. Scott Garrett Independent Chairman of the Board	75	$70.57K USD	Male
Dr. Hing Wong Chief Executive Officer Founder Director	71	$368.2K USD	Male
Ms. Rebecca Byam Chief Financial Officer	69	$154.2K USD	Female
Dr. Peter Rhode Chief Scientific Officer Vice President - Clinical Operations	67	$261.7K USD	Male

Board of Directors

From the proxy statement filed Apr 28, 2026

Directors

serving now

Independent

3 of 4

stated in the proxy

Average tenure

5.8 years

from year joined

CEO also chairs the board

Scott T. Garrett

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Lisa M. Giles	67	2021 5 years	Independent	Audit Committee Compensation Committee	Milestone Pharmaceuticals	$40,000
Rick S. Greene	61	2021 5 years	Independent	Audit Committee · Chair Compensation Committee	None stated	$50,000
Scott T. Garrett Board chair	76	2021 5 years	Independent	Audit Committee Compensation Committee · Chair	MeMed Diagnostics	$60,000
Hing C. Wong CEO	72	2018 8 years	Not independent	None stated	None stated	Paid as CEO

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 28, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Comments

Company Executives

$HCWB Management Team

Mr. Lee Flowers

Mr. Scott Garrett

Dr. Hing Wong

Ms. Rebecca Byam

Dr. Peter Rhode

Board of Directors

Related-party transactions

No related-party transactions disclosed